BIOSIG TECHNOLOGIES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

BSGM

On January 26, 2022, BioSig Technologies, Inc. (the "Company") issued a press release, attached hereto as Exhibit 99.1, announcing that the US Patent Office has allowed a utility patent covering its PURE EP™ noise-filtering technology. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses